Table 1 Baseline descriptive data for the YFS cohort in 2001.

From: The biomarker and causal roles of homoarginine in the development of cardiometabolic diseases: an observational and Mendelian randomization analysis

 

All

Men

Women

Number of subjects (%)

2106

957 (45.4)

1149 (54.6)

Age (years)

31.7 (5.0)

31.6 (5.0)

31.7 (5.0)

Homoarginine (hArg) (µmol/L)

1.85 (0.65)

1.93 (0.61)

1.79 (0.68)

lnhArg (µmol/L)

0.56 (0.34)

0.61 (0.30)

0.52 (0.36)

LDL cholesterol (mmol/L)

3.27 (0.84)

3.42 (0.90)

3.14 (0.77)

HDL cholesterol (mmol/L)

1.29 (0.31)

1.17 (0.27)

1.39 (0.30)

Triglycerides (mmol/L)

1.26 (0.64)

1.41 (0.70)

1.13 (0.55)

Systolic blood pressure (mmHg)

117 (13)

121 (12)

113 (12)

Diastolic blood pressure (mmHg)

72 (11)

73 (11)

69 (10)

C-reactive protein (mg/L)

1.9 (4.0)

1.5 (3.4)

2.1 (4.4)

Glucose (mmol/L)

5.1 (0.85)

5.2 (0.93)

4.9 (0.75)

Insulin (IU/L)

7.7 (5.7)

7.6 (5.8)

7.8 (5.7)

Body mass index (kg/m2)

25.0 (4.4)

25.6 (4.1)

24.4 (4.5)

Waist circumference (cm)

84 (12)

90 (11)

79 (11)

Daily smokers (%)

520 (24.7)

288 (30.1)

232 (20.2)

Family history of CAD (%)

281 (13.3)

123 (12.9)

158 (13.8)

  1. Statistics are mean (SD) or n (%); lnhArg is natural log-transformed. CAD, coronary artery disease; LDL, low-density lipoprotein; HDL, high-density lipoprotein.
Back to article page